Early <i>in vivo</i> assessment of angiostatic therapy efficacy by molecular MRI
Willem J. M. Mulder(Radboud University Nijmegen), Klaas Nicolay(Eindhoven University of Technology), Petra Hautvast(Maastricht University), Daisy W.J. van der Schaft(Maastricht University Medical Centre), Gerben A. Koning(Università Cattolica del Sacro Cuore), Gustav J. Strijkers(University of Amsterdam), Arjan W. Griffioen(Angiogenesis Foundation), Gert Storm(Yong In University), Kevin H. Mayo(University of Minnesota)
Cited by 77
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
Variants in Nicotinic Receptors and Risk for Nicotine Dependence
|American Journal of Psychiatry|2008|641
Consensus guidelines for the use and interpretation of angiogenesis assays
|Angiogenesis|2018|602
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591